Postoperative laser coagulation as retinopexy in patients with rhegmatogenous retinal detachment treated with scleral buckling surgery: a prospective clinical study

Retina. 2002 Dec;22(6):733-9. doi: 10.1097/00006982-200212000-00008.

Abstract

Purpose: To evaluate postoperative laser photocoagulation as retinopexy mode in patients with rhegmatogenous retinal detachment treated with scleral buckling surgery.

Methods: The authors conducted a prospective feasibility study of consecutive patients with rhegmatogenous retinal detachment treated with scleral buckling surgery and postoperative laser during an 18-month period with a minimal follow-up of 6 months. Outcome measures were total retinal reattachment and the occurrence of proliferative vitreoretinopathy (PVR).

Results: A total of 123 patients (124 eyes) were included in this study. Seventy-six percent were phakic and 24% were pseudophakic. Fifty percent presented with one horseshoe tear, 15% with multiple tears, 30% with round breaks, and 5% with no identifiable break. Ten percent presented with a vitreous hemorrhage and 25% with three or four quadrants of detached retina. Six patients had PVR C1. Twelve patients required a postoperative gas injection, five patients received an additional buckle, and five patients underwent a vitrectomy, in four because of PVR. In all patients the retina was fully reattached at the end of follow-up. Planned postoperative laser coagulation took place 1 day to 10 weeks (median 3(1/2) weeks) after buckling surgery. Buckling material was removed in three patients without redetachment.

Conclusion: Postoperative laser coagulation is a feasible alternative retinopexy mode in scleral buckling surgery, with encouraging anatomical results and a low incidence of PVR.

Publication types

  • Clinical Trial

MeSH terms

  • Cryosurgery
  • Feasibility Studies
  • Follow-Up Studies
  • Humans
  • Laser Coagulation / methods*
  • Postoperative Care
  • Prospective Studies
  • Reoperation
  • Retina / surgery*
  • Retinal Detachment / surgery*
  • Scleral Buckling*
  • Sulfur Hexafluoride / therapeutic use
  • Treatment Outcome
  • Visual Acuity
  • Vitrectomy

Substances

  • Sulfur Hexafluoride